Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Inventory Average (2019 - 2025)

Historic Inventory Average for Organogenesis Holdings (ORGO) over the last 7 years, with Q3 2025 value amounting to $36.3 million.

  • Organogenesis Holdings' Inventory Average rose 3469.28% to $36.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.3 million, marking a year-over-year increase of 3469.28%. This contributed to the annual value of $27.2 million for FY2024, which is 270.76% up from last year.
  • Per Organogenesis Holdings' latest filing, its Inventory Average stood at $36.3 million for Q3 2025, which was up 3469.28% from $31.2 million recorded in Q2 2025.
  • Organogenesis Holdings' Inventory Average's 5-year high stood at $36.3 million during Q3 2025, with a 5-year trough of $23.0 million in Q2 2022.
  • Its 5-year average for Inventory Average is $27.3 million, with a median of $27.3 million in 2021.
  • Its Inventory Average has fluctuated over the past 5 years, first crashed by 2050.08% in 2022, then surged by 3469.28% in 2025.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Inventory Average stood at $27.3 million in 2021, then dropped by 9.26% to $24.7 million in 2022, then increased by 13.53% to $28.1 million in 2023, then dropped by 5.17% to $26.6 million in 2024, then skyrocketed by 36.37% to $36.3 million in 2025.
  • Its Inventory Average was $36.3 million in Q3 2025, compared to $31.2 million in Q2 2025 and $27.8 million in Q1 2025.